Snchez-CarranzaJNAlvarezLMarquina-BahenaSSalas-VidalECuevasVJimnezEWet al
Ang II treatment reduces the ABCG1 (an important molecule associated with cholesterol homeostasis) expression, and the overexpression of SIRT6 improves Ang II-induced lipid droplet formation, cholesterol accumulation, and cholesterol efflux capacity, restoring ABCG1 expression, further affecting ABCG1-mediated cholesterol efflux to ameliorate Ang II-induced podocyte injury (Yang et al., 2020)
In Vivo Activity Duration and Dosing Implications The preclinical dosing regimen provides indirect evidence about the peptide's functional duration in vivo, though formal pharmacokinetic parameters remain unmeasured
Imbalance between nitric oxide generation and oxidative stress in patients with peripheral arterial disease: effect of an antioxidant treatment
These include: These medicines may be affected by hydroxocobalamin, or may affect how well it works